7-Year follow-up of a randomized study of allogeneic marrow versus blood stem cell transplantation: lower relapse and higher disease-free survival with blood

被引：0
|
作者：
Powles, R
Mehta, J
Sirohi, B
Kulkarni, S
Treleaven, J
Patel, G
Singhal, S
机构：
来源：
BONE MARROW TRANSPLANTATION | 2003年 / 31卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S249 / S249
页数：1
相关论文
共 50 条
  • [31] Improved graft-versus-host disease-free, relapse-free survival associated with bone marrow as the stem cell source in adults
    Mehta, Rohtesh S.
    de Latour, Regis Peffault
    DeFor, Todd E.
    Robin, Marie
    Lazaryan, Aleksandr
    Xhaard, Alienor
    Bejanyan, Nelli
    de Fontbrune, Flore Sicre
    Arora, Mukta
    Brunstein, Claudio G.
    Blazar, Bruce R.
    Weisdorf, Daniel J.
    MacMillan, Margaret L.
    Socie, Gerard
    Holtan, Shernan G.
    HAEMATOLOGICA, 2016, 101 (06) : 764 - 772
  • [32] Improved survival with ursodeoxycholic acid (UDCA) prophylaxis in allogeneic stem cell transplantation: Long-term follow-up of a randomized study of the Nordic Bone Marrow Transplantation Group.
    Ruutu, T
    Remberger, M
    Remes, K
    Juvonen, E
    Volin, L
    Eriksson, B
    Parkkali, T
    Hagglund, H
    Ringden, O
    BLOOD, 2002, 100 (11) : 111A - 111A
  • [33] Allogeneic T-cell depleted blood stem cell transplantation versus T-cell depleted bone marrow transplantation: a prospective randomized multicenter study
    Cornelissen, J
    Verdonck, L
    Van der Holt, B
    Petersen, E
    Schouten, H
    Russel, L
    Vindelov, L
    Hoglund, M
    Maertens, J
    Maertens, J
    Boogaerts, M
    Lowenberg, B
    BONE MARROW TRANSPLANTATION, 2003, 31 : S40 - S40
  • [34] Effect of CD34+ cell doses on long-term overall and disease-free survival after allogeneic blood or marrow stem cell transplantation for hematologic malignancies: more is better
    Powles, R
    Singhal, S
    Sirohi, B
    Treleaven, J
    Kulkarni, S
    Saso, R
    Goyal, S
    Mehta, J
    BONE MARROW TRANSPLANTATION, 2002, 29 : S113 - S113
  • [35] Enhancement of the anti-tumor efficacy of allogeneic transplantation with the use of blood-derived stem cells: 5-year follow-up of a prospective study comparing marrow and blood allografts.
    Singhal, S
    Powles, R
    Sirohi, B
    Treleaven, J
    Kulkarni, S
    Saso, R
    Tait, D
    Mehta, J
    BLOOD, 2001, 98 (11) : 419A - 419A
  • [36] A double-blind randomised study comparing the efficacy of allogeneic marrow versus blood stem cell transplantation
    Powles, R
    Kulkarni, S
    Mehta, J
    Treleaven, J
    Millar, B
    Shepherd, V
    Tait, D
    Antrum, J
    Neville, F
    Long, S
    Rowland, A
    Shaw, K
    Singhal, S
    BONE MARROW TRANSPLANTATION, 1998, 21 : S35 - S35
  • [37] Graft-versus-host disease-free, relapse-free, second transplant-free survival in allogeneic hematopoietic cell transplantation for genetic disorders
    Kawaguchi, Koji
    Umeda, Katsutsugu
    Miyamoto, Satoshi
    Yoshida, Nao
    Yabe, Hiromasa
    Koike, Takashi
    Kajiwara, Michiko
    Kawaguchi, Hiroshi
    Takahashi, Yoshiyuki
    Ishimura, Masataka
    Sakaguchi, Hirotoshi
    Hama, Asahito
    Cho, Yuko
    Sato, Maho
    Kato, Keisuke
    Sato, Atsushi
    Kato, Koji
    Tabuchi, Ken
    Atsuta, Yoshiko
    Imai, Kohsuke
    BONE MARROW TRANSPLANTATION, 2023, 58 (05) : 600 - 602
  • [38] Graft-versus-host disease-free, relapse-free, second transplant-free survival in allogeneic hematopoietic cell transplantation for genetic disorders
    Koji Kawaguchi
    Katsutsugu Umeda
    Satoshi Miyamoto
    Nao Yoshida
    Hiromasa Yabe
    Takashi Koike
    Michiko Kajiwara
    Hiroshi Kawaguchi
    Yoshiyuki Takahashi
    Masataka Ishimura
    Hirotoshi Sakaguchi
    Asahito Hama
    Yuko Cho
    Maho Sato
    Keisuke Kato
    Atsushi Sato
    Koji Kato
    Ken Tabuchi
    Yoshiko Atsuta
    Kohsuke Imai
    Bone Marrow Transplantation, 2023, 58 : 600 - 602
  • [39] T-Cell Depletion Improves the Composite End Point Graft-Versus-Host Disease-Free, Relapse-Free Survival after Allogeneic Hematopoietic Stem Cell Transplantation
    Simonetta, Federico
    Masouridi-Levrat, Stavroula
    Beauverd, Yen
    Tsopra, Olga
    Tirefort, Yordanka
    Stephan, Caroline
    Polchlopek, Karolina
    Favale, Riccardo
    Dentin, Carole
    Ansari, Marc
    Roosnek, Eddy
    Chalandon, Yves
    BLOOD, 2015, 126 (23)
  • [40] T-cell depletion improves the composite end point graft-versus-host disease-free, relapse-free survival after allogeneic hematopoietic stem cell transplantation
    Simonetta, F.
    Masouridi-Levrat, S.
    Beauverd, Y.
    Tsopra, O.
    Tirefort, Y.
    Stephan, C.
    Polchlopek, K.
    Favale, R.
    Dantin, C.
    Ansari, M.
    Roosnek, E.
    Chalandon, Y.
    BONE MARROW TRANSPLANTATION, 2016, 51 : S223 - S224
12345